Metal Ion Release From an FDA-Approved Metal-on-Metal Total Hip Replacement Implant
Metal Ion Release From an FDA Approved Metal-on-Metal Hip Replacement Implant: A Multi-Center, Randomized Clinical Trial
1 other identifier
interventional
120
2 countries
2
Brief Summary
This is a multi-center, randomized study to compare blood and urine cobalt, chromium, and titanium ion levels of a metal-on-metal articular bearing coupled with two different head sizes to that of a conventional metal-on-polyethylene bearing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2003
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 19, 2009
CompletedFirst Posted
Study publicly available on registry
August 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedAugust 17, 2015
August 1, 2015
7 years
August 19, 2009
August 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cobalt, chromium, and titanium ion levels in blood and urine
Pre-op, 6 months, 1 year, 2 years, 3 years, 5 years
Secondary Outcomes (2)
Hip function
Pre-op, 6 months,1 year, 2 years, 3 years, 5 years
Durability
6 months, 1 year, 2 years, 3 years, 5 years
Study Arms (3)
Metal-on-Polyethylene
OTHERMetal-on-Metal, 28mm femoral head
OTHERMetal-on-Metal, 36mm femoral head
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Undergoing cementless primary total hip replacement
- Receiving acetabular cup of 52mm or greater
- Preoperative level of function and pain same as for conventional hip replacement
- Likelihood of obtaining relief of pain and improved function
- Full skeletal maturity
- Ability to follow instructions
- Good general health
- Willing to return for follow-up evaluations
- X-ray evaluation confirming the presence of NIDJD
- Femoral and acetabular bone stock that is sufficient, regarding strength and shape, and suitable to receive the implants
You may not qualify if:
- Age less than 40 years or greater than 80 years at time of surgery
- Patients templated to receive an acetabular component smaller than 52mm in diameter
- Presence of a previous prosthetic hip replacement device in the hip joint to be operated
- Previous girdlestone procedure or surgical fusion of the hip to be operated
- Acute femoral neck fracture
- Above knee amputation of the contralateral and/or ipsilateral leg
- Patients with a diagnosis of inflammatory degenerative arthritis
- Skeletally immature
- Evidence of active infections that may spread to other areas of the body
- The presence of a highly communicable disease that may limit follow-up
- Presence of known active metastatic or neoplastic disease
- Significant neurologic or musculoskeletal disorders or disease that may adversely affect gait or weightbearing
- Any previous hip surgery or conditions that may interfere with the total hip replacement's survival or outcome
- Any patient believed to be unwilling or unable to comply with a rehabilitation program for a cementless total hip replacement or indicates difficulty to return for follow-up
- Patient is know to be pregnant, a prisoner, mentally incompetent, and/or alcohol or drug abuser
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anderson Orthopaedic Research Institutelead
- University of Western Ontario, Canadacollaborator
- DePuy Orthopaedicscollaborator
Study Sites (2)
Anderson Orthopaedic Research Institute
Alexandria, Virginia, 22306, United States
Department of Orthopaedic Surgery, University of Western Ontario
London, Ontario, N6A5A5, Canada
Related Publications (1)
Engh CA Jr, MacDonald SJ, Sritulanondha S, Thompson A, Naudie D, Engh CA. 2008 John Charnley award: metal ion levels after metal-on-metal total hip arthroplasty: a randomized trial. Clin Orthop Relat Res. 2009 Jan;467(1):101-11. doi: 10.1007/s11999-008-0540-9. Epub 2008 Oct 15.
PMID: 18855089RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
C. Anderson Engh, Jr., MD
Anderson Orthopaedic Research Institute
- PRINCIPAL INVESTIGATOR
Steven J. MacDonald, MD
Department of Orthopaedic Surgery, University of Western Ontario
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic Surgeon
Study Record Dates
First Submitted
August 19, 2009
First Posted
August 20, 2009
Study Start
October 1, 2003
Primary Completion
October 1, 2010
Study Completion
October 1, 2013
Last Updated
August 17, 2015
Record last verified: 2015-08